1. Chen, Yang, Zhao, Yin, Yang, Xiaojing, Ma, Jun, Liu, Na. 2022. USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma. In Nature communications, 13, 501. doi:10.1038/s41467-022-28158-2. https://pubmed.ncbi.nlm.nih.gov/35079021/
2. Ekstrom, Thomas L, Hussain, Sajjad, Bedekovics, Tibor, Johnsen, Steven A, Galardy, Paul J. . USP44 Overexpression Drives a MYC-Like Gene Expression Program in Neuroblastoma through Epigenetic Reprogramming. In Molecular cancer research : MCR, 22, 812-825. doi:10.1158/1541-7786.MCR-23-0454. https://pubmed.ncbi.nlm.nih.gov/38775808/
3. Chen, Sisi, Zhou, Binghai, Huang, Wei, Wang, Wei, Xie, Peiyi. 2023. The deubiquitinating enzyme USP44 suppresses hepatocellular carcinoma progression by inhibiting Hedgehog signaling and PDL1 expression. In Cell death & disease, 14, 830. doi:10.1038/s41419-023-06358-y. https://pubmed.ncbi.nlm.nih.gov/38097536/
4. Lan, Xianjiang, Atanassov, Boyko S, Li, Wenqian, Workman, Jerry L, Dent, Sharon Y R. . USP44 Is an Integral Component of N-CoR that Contributes to Gene Repression by Deubiquitinating Histone H2B. In Cell reports, 17, 2382-2393. doi:10.1016/j.celrep.2016.10.076. https://pubmed.ncbi.nlm.nih.gov/27880911/
5. Zeng, Liang, Li, Ying-Qing, He, Shi-Wei, Liu, Na, Wang, Hai-Yun. . The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma. In Neuro-oncology, 27, 492-507. doi:10.1093/neuonc/noae175. https://pubmed.ncbi.nlm.nih.gov/39215663/
6. Londra, Dora, Mastoraki, Sophia, Bournakis, Evangelos, Rampias, Theodoros, Lianidou, Evi S. 2021. USP44 Promoter Methylation in Plasma Cell-Free DNA in Prostate Cancer. In Cancers, 13, . doi:10.3390/cancers13184607. https://pubmed.ncbi.nlm.nih.gov/34572834/
7. Park, Jae Min, Lee, Jae Eun, Park, Chan Mi, Kim, Jung Hwa. 2019. USP44 Promotes the Tumorigenesis of Prostate Cancer Cells through EZH2 Protein Stabilization. In Molecules and cells, 42, 17-27. doi:10.14348/molcells.2018.0329. https://pubmed.ncbi.nlm.nih.gov/30622230/
8. Chen, Xin, Wu, Xiaotang, Lei, Wen. 2020. USP44 hypermethylation promotes cell proliferation and metastasis in breast cancer. In Future oncology (London, England), 17, 279-289. doi:10.2217/fon-2020-0415. https://pubmed.ncbi.nlm.nih.gov/32956592/
9. Liu, Yan, Yuan, Mengmeng, Xu, Xinxin, Yu, Wei, Ji, Meiju. 2024. USP44 inactivation accelerates the progression of thyroid cancer by inducing ubiquitylation and degradation of p21. In International journal of biological sciences, 20, 5223-5238. doi:10.7150/ijbs.99817. https://pubmed.ncbi.nlm.nih.gov/39430240/
10. Zhou, Huanhuan, Yang, Lu, Lin, Xiao, Li, Rong, Lai, Keng Po. 2023. Integrated network findings reveal ubiquitin-specific protease 44 overexpression suppresses tumorigenicity of liver cancer. In Aging, 15, 4304-4318. doi:10.18632/aging.204733. https://pubmed.ncbi.nlm.nih.gov/37204480/